You can view the entire product mix with sales quantity & value along with percentage contribution from each individual product for Parenteral Drugs (India) Ltd.

The average Revenue of companies in the Sector is 25.594 B with a standard deviation of 45.937 B. Parenteral Drugs India Ltd's Revenue of - is significantly outside the interquartile range and is ...

Virtually addressing an event organized by Sebi, Buch said the Indian economy has a "huge opportunity" and all the necessary technological tools have been put in place as part of a larger ecosystem ...

This decision was made based on the more pronounced pharmacokinetic properties of the parenteral drug products and the associated potential for rapid onset of severe adverse events when the drugs ...

Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) ...

and in accordance with the requirements of Sub clause 16(k) of Para A of part A of Schedule III of Listing Regulations, we wish to inform you that the Hon''ble NCLT, Mumbai has approved the ...

and in accordance with the requirements of Sub- clause 16(k) of Para A of part A of Schedule III of Listing Regulations, we wish to inform you that the Hon''ble NCLT, Mumbai has approved the ...

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2024. The list includes several groundbreaking therapies that are expected to change the ...

The biotech industry’s DeepSeek moment came last fall.